In DEN/CCl4-induced liver fibrosis mouse model, we preliminary proofed that ADSC-EXO administration for 3 weeks dramatically reversed the fibrotic phenotypes and restored hepatic function compared with control group, including liver morphology recovery, liver/body weight ratio decreased and ALT/AST remission. Here, GPT is linked to Hepatic fibrosis.